ACTIVE

Dr. Helena Maes, inwendige ziekten-hematologie

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result158,7 k €-1,4 %over 1 year
Gross margin240,1 k €-1,4 %over 1 year
Equity29,2 k €+33,3 %over 1 year

Identity

Source · BCE/KBO

Dr. Helena Maes, inwendige ziekten-hematologie is a Private limited company incorporated in 2016. Its main activity is: Specialist medical practice activities. Its registered office is in Keerbergen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0662.643.424
Incorporation
16/09/2016
Legal form
Private limited company
Registered office
Raambeekweg 19
3140 Keerbergen · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Signals
ProfitablePositive cashflowPositive EBITDA

Financials

Source · NBB, 10 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin240,1 k €243,5 k €185,4 k €177,6 k €166 k €
EBITDA239,6 k €242,8 k €184,9 k €176,9 k €163,8 k €
Operating result206,1 k €211,6 k €161,4 k €160,2 k €153,3 k €
Net result158,7 k €161 k €124,4 k €123,9 k €120,1 k €
Balance sheet
Equity29,2 k €21,9 k €20,9 k €20,5 k €20,6 k €
Total assets220,3 k €237,1 k €208,7 k €219,6 k €164,7 k €
Cash136,6 k €102,9 k €110,2 k €92,6 k €73,6 k €
Debts190,5 k €214,6 k €187,6 k €198,9 k €143,4 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active

Active mandates

DirectorMandates in this companyPeriod
Klaas Beckers
Directorsince 18/10/2023
Helena Maes
Directorsince 13/09/2016Managersince 13/09/2016ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202602/07/202504/07/202422/06/202321/06/202228/05/2021
General meeting02/04/202603/06/202504/06/202424/05/202307/06/202219/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 10 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202502/04/202630/06/2026DutchPDF
Micro model31/12/202403/06/202502/07/2025DutchPDF
Micro model31/12/202304/06/202404/07/2024DutchPDF
Micro model31/12/202224/05/202322/06/2023DutchPDF
Micro model31/12/202107/06/202221/06/2022DutchPDF
Micro model31/12/202019/05/202128/05/2021DutchPDF
Micro model31/12/201902/06/202018/06/2020DutchPDF
Micro model31/12/201804/06/201920/08/2019DutchPDF
Micro model31/12/201705/06/201804/07/2018DutchPDF
Micro model31/12/201606/06/201705/07/2017DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active

Active mandates

DirectorMandates in this companyPeriod
Klaas Beckers
Directorsince 18/10/2023
Helena Maes
Directorsince 13/09/2016Managersince 13/09/2016ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates04/12/2023
    BENOEMING BESTUURDER
    PDF
  • Mandates30/08/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other20/09/2016
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings5 filings
Mandates
Klaas Beckers
Helena Maes
20162017201820192020202120222023202420252026
Dr. Helena Maes, inwendige ziekten-hematologie
Raambeekweg 19, 3140 Keerbergen
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Raambeekweg 19, 3140 KeerbergenCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00222266

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Dr. Helena Maes, inwendige ziekten-hematologieCurrent
accounts 2016 → 2025
Accounts 2025 · 2026-00222266

Events

  1. 2025
    Annual accounts 2025158,7 k €↓
  2. 2024
    Annual accounts 2024161 k €↑
  3. 2023
    Annual accounts 2023124,4 k €↑
  4. 2022
    Annual accounts 2022123,9 k €↑
  5. 2021
    Annual accounts 2021120,1 k €
  6. 16/09/2016
    IncorporationPrivate limited company